FIG4 Gene Mutation Detection Assays for Charcot-Marie-Tooth Disease
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic and therapeutic approaches for Charcot-Marie-Tooth disease (CMT) lack effective characterization of the molecular basis and improved diagnostics, leading to inadequate management of the disease.
Innovation Solution
Development of assays for detecting mutations in the FIG4 gene, including nucleic acid hybridization and protein analysis techniques, to identify variant FIG4 alleles and polymorphisms associated with CMT, enabling early diagnosis and potential treatment strategies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current diagnostic approaches are used for CMT, then disease management is inadequate, but development of new assays increases diagnostic capability
Solution Approach 1:
The diagnostic approach is segmented into multiple specialized assays: nucleic acid hybridization assays for detecting FIG4 gene mutations, protein analysis techniques for detecting FIG4 polypeptide variants, and functional assays for assessing cellular responses. Each assay targets specific aspects of the disease, improving overall diagnostic precision while allowing selection based on clinical needs
Solution Approach 2:
The developed assay system serves multiple functions: it detects FIG4 gene mutations, identifies variant FIG4 alleles, characterizes molecular basis of CMT, and enables early diagnosis. This multi-functionality improves measurement precision across different diagnostic dimensions without requiring entirely separate diagnostic systems
2Loss of information
If molecular characterization of CMT is improved, then disease understanding increases, but diagnostic complexity increases
Solution Approach 1:
The patent employs intermediary molecules and techniques: nucleic acid probes as intermediaries to detect mutant FIG4 sequences, antibodies as intermediaries to detect variant FIG4 polypeptides, and reporter systems as intermediaries to visualize assay results. These intermediaries enable comprehensive molecular characterization while maintaining manageable diagnostic complexity through standardized detection mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution allows for accurate detection of FIG4 gene mutations, facilitating early intervention and improved management of CMT, potentially delaying disease progression and improving quality of life for patients.
Implementation Method 1
detecting the presence or absence of a variant FIG4 gene in a biological sample from the subject
Data Source
AI summary
The present invention relates to neuropathy, in particular to mutations in the FIG4 gene. The present invention also provides assays for the detection of variant FIG4 alleles, and assays for detecting FIG4 polymorphisms and mutations associated with disease states.